Partnership potential FLI actively collaborates with international partners (NEIKER, ANSES, INRAe, Sciensano, Moredun, Royal GD) and collaborates on disease prevention and health initiatives, indicating an openness to joint programs, funded research, and technology transfer opportunities.

Vaccination & disease focus Recent activity includes a webinar on Newcastle Disease vaccination and a strong emphasis on prevention, diagnostics, and control of animal diseases, suggesting opportunities to offer vaccines, diagnostic tools, surveillance platforms, and training services aligned with EU-wide veterinary health priorities.

Leadership & governance A new president appointed in 2023 signals potential strategic shifts or expansion plans; engaging with executive leadership could uncover priority programs, funding directions, and collaboration roadmaps for large-scale animal health initiatives.

Technology stack FLI uses a mix of analytics, web, database, and development tools (SAS, MongoDB, MySQL, Python, TYPO3, jQuery, Piwik, Adobe Creative Suite), indicating readiness for data analytics, digital health platforms, and knowledge management projects that you could support with software, integration, or training services.

Scale & funding With a revenue range of $10M-$25M and 201-500 employees, FLI represents a mid-scale public research entity with potential needs for scalable instrumentation, high-throughput diagnostics, cloud-based data solutions, and cross-border project management support within European funding frameworks.